Severity of Illness Index
"Severity of Illness Index" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
| Descriptor ID |
D012720
|
| MeSH Number(s) |
E05.318.308.980.438.475.456.500 N05.715.360.300.800.438.375.364.500 N06.850.520.308.980.438.475.364.500
|
| Concept/Terms |
Severity of Illness Index- Severity of Illness Index
- Illness Index Severities
- Illness Index Severity
- Index Severities, Illness
- Index Severity, Illness
|
Below are MeSH descriptors whose meaning is more general than "Severity of Illness Index".
Below are MeSH descriptors whose meaning is more specific than "Severity of Illness Index".
This graph shows the total number of publications written about "Severity of Illness Index" by people in this website by year, and whether "Severity of Illness Index" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2006 | 0 | 6 | 6 |
| 2007 | 0 | 4 | 4 |
| 2008 | 1 | 2 | 3 |
| 2009 | 0 | 4 | 4 |
| 2010 | 1 | 4 | 5 |
| 2011 | 1 | 5 | 6 |
| 2012 | 0 | 4 | 4 |
| 2013 | 1 | 2 | 3 |
| 2014 | 0 | 6 | 6 |
| 2015 | 1 | 4 | 5 |
| 2016 | 0 | 3 | 3 |
| 2017 | 0 | 3 | 3 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 4 | 4 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 1 | 1 |
| 2024 | 0 | 3 | 3 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Severity of Illness Index" by people in Profiles.
-
Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial. Heart. 2025 Jun 26; 111(14):686-694.
-
Treating moderate-to-severe atopic dermatitis with benralizumab: results from the HILLIER study, a plain language summary. Immunotherapy. 2024; 16(10):641-648.
-
Is Coronary Physiology Assessment Valid in Special Circumstances?: Aortic Stenosis, Atrial Fibrillation, Left Ventricular Hypertrophy, and Other. Cardiol Clin. 2024 Feb; 42(1):21-29.
-
Practical Use of Patient-Reported Outcome Measures in Chronic Kidney Disease-Associated Pruritus. J Ren Nutr. 2024 Jul; 34(4):294-301.
-
Cardiovascular and Bleeding Outcomes with Anticoagulants across Kidney Disease Stages: Analysis of a National US Cohort. Am J Nephrol. 2021; 52(3):199-208.
-
Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity. Parkinsonism Relat Disord. 2021 03; 84:105-111.
-
Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19. Med Hypotheses. 2021 Jan; 146:110363.
-
Effects of intraaortic balloon counterpulsation on translesional coronary hemodynamics. Catheter Cardiovasc Interv. 2020 10 01; 96(4):871-877.
-
Vive la difference: Factors and mechanisms predicting discrepancy between iFR and FFR. Catheter Cardiovasc Interv. 2019 09 01; 94(3):364-366.
-
Evaluation of the severity of mitral stenosis in patient with pulmonary hypertension: Role of exercise hemodynamics. Catheter Cardiovasc Interv. 2019 Aug 01; 94(2):301-307.